WCC Form 144 Filing: 3,160 Shares Proposed Sale via UBS

Rhea-AI Filing Summary

Wesco International (WCC) Form 144 notice: An insider has filed to sell 3,160 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $714,995. The shares to be sold were acquired from the issuer as equity awards earlier in 2025: 2,159 shares from a performance stock unit grant on 02/13/2025 and three separate restricted stock unit grants totaling 1,001 shares on 02/16/2025, 02/17/2025, and 03/01/2025. The approximate sale date listed is 08/26/2025. The filer certifies no undisclosed material adverse information and indicates no sales by this person in the past three months.

Positive

• Full disclosure of the broker, number of shares, aggregate market value, and approximate sale date
• Acquisition details provided showing shares originate from issuer grants (PSU and RSUs) with specific dates
• Seller attests they are not aware of undisclosed material adverse information, supporting regulatory compliance

Negative

• Insider sale of 3,160 shares valued at $714,995 could be perceived negatively by some investors
• No explicit mention in the filing that the sale is pursuant to a pre-established Rule 10b5-1 trading plan

Insights

Securities Analyst

TL;DR: Routine insider sale filing for compensation shares; modest size relative to typical institutional trades suggests limited market impact.

The Form 144 reports a proposed sale of 3,160 common shares valued at $714,995 through UBS on the NYSE, comprised entirely of equity awards

Corporate Governance Expert

TL;DR: Disclosure aligns with governance and securities-law obligations; documentation of award origins strengthens compliance posture.

The filing clearly discloses the nature and dates of acquisition for the securities

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3160	714995	48662715	08/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2025	PSU	Issuer			2159	08/26/2025	NA
Common	02/16/2025	RSU	Issuer			277	08/26/2025	NA
Common	02/17/2025	RSU	Issuer			366	08/26/2025	NA
Common	03/01/2025	RSU	Issuer			358	08/26/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Wesco International's (WCC) Form 144 disclose?

The filing discloses a proposed sale of 3,160 common shares via UBS on the NYSE with aggregate market value of $714,995 and an approximate sale date of 08/26/2025.

When were the shares to be sold acquired?

The shares were acquired as equity awards from the issuer: 02/13/2025 (PSU, 2,159 shares), 02/16/2025 (RSU, 277 shares), 02/17/2025 (RSU, 366 shares), and 03/01/2025 (RSU, 358 shares).

Who is the broker handling the sale in the WCC Form 144?

The broker listed is UBS Financial Services Inc., 1000 Harbor Blvd, Weehawken, NJ.

Does the Form 144 indicate recent sales by the same person?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the filing confirm the insider has undisclosed material information?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.